[Treatment of arterial hypertension in patients with benign prostatic hyperplasia].
Arterial hypertension (AH) is encounted in 20-30% of patients with benign prostatic hyperplasia (BPH). Alpha1-adrenoblockers have limited application in such patients and should be used as a first-line therapy only in those BPH patients who already receive them for BPH. In other cases AH is managed with thiaside diuretics, beta-adrenoblockers, ACE inhibitors or calcium antagonists. A drug of choice for correction of urination disorders in BPH hypertensive patients is alpha1A-adrenoblocker tamsulozin.
Ivleva
A Ia
AIa
Sivkov
A V
AV
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications*
D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics